Long-term efficacy and safety of efavirenz dose reduction to 200 mg once daily in a caucasian patient with HIV
A 48 -year-old Caucasian male patient presented with severe adverse drug events (ADEs) while being treated with a standard dose (600mg/day) of efavirenz. The patient's clinical course was favourable; however, he also described intense nightmares, cramps in his legs and anxiety disturbances that...
Gespeichert in:
Veröffentlicht in: | Clinical drug investigation 2010-06, Vol.30 (5), p.405 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!